Is there hope for a primary progressive multiple sclerosis treatment? Researchers are pretty excited about Ocrelizumab for PPMS. This drug has sent researchers over the moon. Professor Lawrence Stinman from Stanford University states, “The results are on the mild side, but it’s a great start. An absolute gift – it’s the first time that anything’s worked in the field.”
In addition to helping PPMS, Ocrelizumab shows, “a strong effect in suppressing relapse and MRI lesions in clinical trials for RRMS, with a relatively mild side-effects profile.” Look for more news on this new drug in the coming months as it moves forward with the U.S. Food and Drug Administration.
MS Research Australia. “Ocrelizumab shows the way forward for research into treatments for progressive forms of MS”. January 27, 2016. http://www.msra.org.au/ocrelizumab-shows-way-forward-research-treatments-progressive-forms-msPP. Image from this site.